AGTX — what changed in the latest 10-K
A section-by-section comparison of AGTX's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-K · 2026-07-01 vs the prior 10-K · 2025-07-16
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| Business | Text added/removed | 0 | 0 | ~2 | 41 |
| Risk factors | No paragraph-level changes | 0 | 0 | 0 | 5 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| MD&A | Text added/removed | +8 | −10 | ~2 | 6 |
| Market risk (Item 7A) | No paragraph-level changes | 0 | 0 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-K · 2026-07-01
For the year ended March 31, 2026, we incurred total research and development expenses of $125,079 as compared to $180,987 for our year ended March 31, 2025, a decrease of $55,908. The decrease was mainly related to an increase in R&D consulting, offset by a decrease in supplies and materials and pa…
For the year ended March 31, 2026, general and administrative expenses were $68,072 as compared to $69,898 for our year ended March 31, 2025, a decrease of $1,826.
For the year ended March 31, 2026, foreign exchange gain was $24,584 as compared to foreign exchange loss of $11,128 for the year ended March 31, 2025.
For the year ended March 31, 2026, cash used from our operating activities was $108,529 of cash as compared to a use of cash of $125,078 during the year ended March 31, 2025.
For the year ended March 31, 2026, cash from financing was $110,450 versus $100,000 for our year ended March 31, 2025. Cash from financings during the year ended March 31, 2026 and 2025, respectively, consisted of $110,450 and $100,000 from loan proceeds received.
Text removed vs the prior filing · source: 10-K · 2025-07-16
For the year ended March 31, 2025, professional fees were $262,366 as compared to $222,999 for the year ended March 31, 2024, an increase of $39,367. The Increase in professional fees mainly to an increase in accounting and consulting fees.
For the year ended March 31, 2025, we incurred total research and development expenses of $180,987 as compared to $175,268 for our year ended March 31, 2024, an increase of $5,719. The increase was mainly related to increase in R&D consulting costs.
For the year ended March 31, 2025, general and administrative expenses were $69,898 as compared to $346,543 for our year ended March 31, 2024, a decrease of $276,645. The decrease was mainly related to a decrease in royalty fee we incurred related to patents in the prior period, compared to the prio…
For the year ended March 31, 2025 and 2024, we received R&D credits totaling $0 and $198,371 related to our R&D efforts that occurred at our Agentix Australia Pty Ltd entity. We did not receive any R&D credits for the comparable period ended March 31, 2025.
For the year ended March 31, 2025, cash used from our operating activities was $125,078 of cash as compared to a use of cash of $110,429 during the year ended March 31, 2024.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice